<?xml version="1.0" encoding="UTF-8"?>
<p>The pteridine moiety of the co-crystallised ligand, methotrexate interacts with the active site of DHFR by two different interactions
 <xref rid="CIT0042" ref-type="bibr">
  <sup>42</sup>
 </xref>; hydrogen bonding of the two amino groups with 
 <bold>Ile7</bold> and 
 <bold>Glu30</bold> (distance: 1.93 and 1.73 Å, respectively), and arene–arene interaction with 
 <bold>Phe34</bold>. Moreover, the amide oxygen forms H-bond acceptor with the side chain of 
 <bold>Asn64</bold> (distance: 2.64 Å), while the two oxygen of the carboxylic group shares the binding by two H-bond acceptors with 
 <bold>Arg70</bold> (distance: 2.68 and 3.12 Å, respectively). This beside many hydrophobic interactions with various amino acid residues: 
 <bold>Ile7</bold>, 
 <bold>Val8</bold>, 
 <bold>Ala9</bold>, 
 <bold>Tyr22</bold>, 
 <bold>Arg28</bold>, 
 <bold>Phe31</bold>, 
 <bold>Gln35</bold>, 
 <bold>Ser59</bold>, 
 <bold>Ile60</bold>, 
 <bold>Pro61</bold>, 
 <bold>Val115</bold>, 
 <bold>Tyr121</bold>, and 
 <bold>Thr136</bold>, as shown in (
 <xref ref-type="fig" rid="F0005">Figure 5</xref>).
</p>
